Drug Topics
APRIL 7, 2025
Researchers explored various types of self-expression among pharmacists and how they were associated with experience in community pharmacy-led deprescribing.
PhRMA
APRIL 7, 2025
For more than four decades since the passage of the Hatch-Waxman Act, the U.S. generic drug market has provided patients with low-cost alternatives to brand-name medicines, saving the health care system billions while preserving incentives for biopharmaceutical innovation. Today, low-cost generics account for nine out of every 10 prescriptions dispensed in the United States and come with an average copay of about six dollars.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
APRIL 7, 2025
This years conference is taking place from April 10 to 12 in Austin, Texas.
PharmaVoice
APRIL 7, 2025
So far, the science and safety seem solid. But is the world emotionally ready to shift the responsibility of contraception to men?
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Topics
APRIL 7, 2025
Type 1 diabetes can cause long-term complications, including the development of autoimmune diseases.
PharmaVoice
APRIL 7, 2025
The FDA is much more flexible in approving first-in-class drugs compared to European regulators.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Pharmacy Times
APRIL 7, 2025
Tirzepatide-treated patients with chronic kidney disease (CKD), obesity, and heart failure with preserved ejection fraction (HFpEF) had improved renal function both by cystatin C and creatinine.
Drug Topics
APRIL 7, 2025
In a conversation with David Blair, CEO of LucyRx, he discussed his companys unique business model and how it is giving back to patients, providers, and plan sponsors alike.
Hospital Pharmacy Europe
APRIL 7, 2025
Theranostics integrates diagnostic and therapeutic radiopharmaceuticals targeting the same molecular structures delivering a one-two punch for personalised cancer care. In his latest commentary, Professor Alain Astier discusses how the radionuclide 177Lu and 177Lu-based radioligands have gained traction in treating various conditions, including neuroendocrine tumours and metastatic prostate cancer.
Fierce Healthcare
APRIL 7, 2025
The Centers for Medicare and Medicaid Services finalized a substantial increase to Medicare Advantage benchmark payments over its advance notice earlier this year.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
The FDA Law Blog
APRIL 7, 2025
Come together with leaders from the pharmaceutical, biotechnology, and diagnostic industries to unpack huge changes at the American Conference Institutes 23rd Advanced Summit on Life Sciences Patents , which is scheduled to take place from May 19-20, 2025 at the New York Bar Association in New York, NY. In a year of major change and outstanding questions, growing scrutiny on patent protection and drug pricing, and uncertainty around global price control measures and the Inflation Reduction Act,
Pharmacy Times
APRIL 7, 2025
Fatty acid metabolism plays a critical role in treatment responses.
Pharmaceutical Technology
APRIL 7, 2025
The European Commission (EC) has granted approval for AstraZeneca's Imfinzi plus chemotherapy for treating resectable NSCLC in adults.
Fierce Healthcare
APRIL 7, 2025
HHS Secretary Kennedy is instructing the CMS to analyze a New York amendment that will remake how the state administers its home health Medicaid program, which has prompted strong backlash from lawmakers and advocacy groups.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
pharmaphorum
APRIL 7, 2025
Buoyed by data from a phase 1b/2a trial, Roche has said it plans to start a phase 3 programme for an Alzheimer's drug from its Brainshuttle programme.
Pharmacy Times
APRIL 7, 2025
Kayla Johnson, PharmD, BCPS, BCPP, highlights how integrating pharmacists into neurology clinics drives significant cost savings, high intervention acceptance rates, and improved care coordination.
Fierce Healthcare
APRIL 7, 2025
A nearly 200-page report from the nonprofit outlines a slew of headwinds facing emergency care and offers evidence-based policy recommendationsoften focused on realigning and increasing pay.
Pharmacy Times
APRIL 7, 2025
Stephanie Miller, PhD discusses how artificial intelligence can revolutionize medical research by assisting in drug development and potentially providing more targeted treatments across various diseases.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Fierce Healthcare
APRIL 7, 2025
The first three months of 2025 saw a steady volume of funding deals, as digital health startups raised $3 billion, compared to $2.7 billion raised the same quarter last year.
Pharmacy Times
APRIL 7, 2025
Sophie Jabban discusses findings from 2 studies that highlight how geographic location, race, ethnicity, and social determinants of health contribute to delays in initiating chemoradiation for patients with cervical cancer.
Fierce Healthcare
APRIL 7, 2025
The Coalition for Health AI will add a new capability to its national model card registry for health systems to report standardized metrics on how specific AI models are performing in their systems.
Pharmacy Times
APRIL 7, 2025
Enriqueta Felip, MD, PhD, discussed the benefits of subcutaneous pembrolizumab for patients with metastatic nonsmall cell lung cancer.
pharmaphorum
APRIL 7, 2025
Neuroscience isn't listed as one of the top R&D priorities at GSK, but a new alliance with ABL Bio adds to the sense that its focus may be shifting.
Pharmacy Times
APRIL 7, 2025
The multiple myeloma landscape is evolving, with bispecific T-cell engagers offering hope.
pharmaphorum
APRIL 7, 2025
Epsilogen has bought TigaTx, pooling their resources to create what it says will be a leader in 'pan-isotope' cancer antibodies
Pharmacy Times
APRIL 7, 2025
Scott Soefje, PharmD, MBA, BCOP, FCCP, FHOPA, discusses a case study of a patient with metastatic esophageal squamous cell carcinoma.
Pharmaceutical Commerce
APRIL 7, 2025
In the second part of her video interview with Pharma Commerce Editor Nicholas Saraceno, Kimberly Westrich, chief strategy officer at the National Pharmaceutical Council, describes how accumulators, maximizers, and AFPs are impacting patients, manufacturers, and healthcare ecosystems, and how that all ties into the presentation she participated in.
Pharmacy Times
APRIL 7, 2025
Scott Soefje, PharmD, MBA, BCOP, FCCP, FHOPA, offers insights for oncology pharmacists treating patients with metastatic esophageal squamous cell carcinoma.
Pharmaceutical Commerce
APRIL 7, 2025
The latest news for pharma industry insiders.
Pharmacy Times
APRIL 7, 2025
Glucagon-like peptide-1 (GLP-1) analogs demonstrate potential to address multiple pathological processes in Alzheimer disease, with promising early research suggesting cognitive improvements and potential for future treatment.
Fierce Healthcare
APRIL 7, 2025
GroundGame.Health, Umoja Health, and Ujima are scaling a Medicaid reimbursed Food as Medicine model to improve nutrition, reduce healthcare costs, and support underserved communities.
Pharmaceutical Technology
APRIL 7, 2025
Eisai/Biogens Leqembi (lecanemab) was fully approved in the US in July 2023, and Eli Lillys Kisunla (donanemab) in July 2024.
pharmaphorum
APRIL 7, 2025
Changing Faces - Pharma and Biotech Hires - March 2025 Jonah.
Expert insights. Personalized for you.
499 
Let's personalize your content